ABBV.NYSEAbbvie INC

Form 4: AbbVie Director Roxanne Austin Reports Stock Unit Award

Sentiment:

Statement of Changes in Beneficial Ownership


AbbVie Inc. director Roxanne S. Austin reported the acquisition of 1,118 restricted stock units under the company's incentive stock program.

Summary

  • Roxanne S. Austin, a Director at AbbVie Inc., was awarded 1,118 restricted stock units (RSUs) on May 8, 2026.
  • These RSUs are part of the AbbVie Amended and Restated 2013 Incentive Stock Program.
  • The RSUs will be settled on a one-to-one basis in shares of AbbVie common stock.
  • Settlement will occur upon the earlier of the director's separation from service, death, or a change in control.
  • Following this transaction, Austin beneficially owns 39,576 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity award to a director rather than a significant financial event or strategic shift.

Positives

  • Director Austin received an award of restricted stock units, indicating continued equity-based compensation and alignment with the company's performance.
  • The award of 1,118 RSUs suggests ongoing incentive for leadership to remain engaged with the company's long-term success.

Risks

  • The value of the restricted stock units is subject to the future performance of AbbVie's stock price.
  • Vesting and settlement are contingent upon specific events such as separation from service, death, or a change in control, introducing timing uncertainty.

Future Outlook

The future value of the awarded restricted stock units is dependent on AbbVie's stock performance and the occurrence of specific events like separation from service, death, or change in control.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to directors is a common practice in the pharmaceutical and biotechnology industry to align executive interests with shareholder value and incentivize long-term performance.

Stakeholder Impact

  • Shareholders: The award reinforces director alignment with shareholder interests through equity compensation.
  • Employees: This type of compensation structure is typical for executive and director levels within the company.
  • Management: The award is part of the established incentive program for leadership.

Next Steps

  • Settlement of restricted stock units upon the occurrence of director's separation from service, death, or change in control.

Key Dates

DateDescription
05/08/2026Transaction Date for the award of restricted stock units.
05/12/2026Date of signature for the filing.

Keywords

AbbVie Inc., ABBV, Form 4, Roxanne S. Austin, Restricted Stock Units, Incentive Stock Program, Director Compensation, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.